Last deal

$2M

Amount

Series B

Stage

04.11.2014

Date

3

all rounds

$3M

Total amount

General

About Company
Parabase Genomics is a molecular diagnostics company focused on developing treatments for genetic disorders.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company's NewbornDx™ test provides an accurate molecular profile on 500+ newborn related genes using dried blood spots within 10 days, allowing physicians to diagnose common symptomology found in neonates without depending on severe phenotypes to nominate a single gene test for a given disorder.
Contacts